Summary
Latest filing:
Steve Elms files SEC Form 4 reports at ADMA BIOLOGICS, INC. (ADMA). 8 SEC Form 4 filings on record going back to 2024, most recently on 9 March 2026. Most recent open-market trade: bought $108K of ADMA on 9 March 2026. Lifetime open-market purchases: $253K. Lifetime open-market sales: $8.83M. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
18Every recent SEC Form 4 transaction Steve Elms has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | +0.10% |
| Avg 30-day return | -39.14% |
| Avg 90-day return | -53.76% |
| Best 30-day return | -36.84% |
Trading Pattern
InsiderAlpha's records for Steve Elms go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. The typical open-market purchase is $84K (3 buys totaling $253K). The largest single buy on record is $110K of ADMA in 2026. Sales side: 3 recorded sales totaling $8.83M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Steve Elms files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adam S. Grossman - $1.74M of ADMA open-market activity in the last 12 months
- Jerrold B. Grossman - $251K of ADMA open-market activity in the last 12 months
- Kaitlin M. Kestenberg-Messina - $158K of ADMA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Steve Elms?
Steve Elms is a corporate insider of ADMA BIOLOGICS, INC. (ADMA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Steve Elms last file a Form 4?
The most recent primary Form 4 on record is dated 9 March 2026, one of 8 filings going back to 2024.
Has Steve Elms been buying or selling stock?
Recorded transactions: 3 open-market purchases ($253K) and 3 open-market sales ($8.83M) across all tracked filings.
How accurate is Steve Elms's historical track record?
Across 3 tracked purchases, Steve Elms averaged -39.1% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Steve Elms's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Steve Elms and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial